Interview, Podcast
Varda's Landing, Peter Thiel, & the Future of El Segundo, Delian Asparouhov, Founders Fund
- Personal development may stagnate if new goals are not set after age 35, while the Midas list's top 10 is projected to see half of its members become forgotten within approximately a decade, suggesting that sustained top-tier investing requires serious user operating experience and potentially a temporary shift to a portfolio company.
- Varda expects to scale with new announcements emerging within about two years, anticipate permission costs of $3.5–4 million by the fifth or sixth mission, and aims to eventually host a human on board for maintenance, while forecasting a 2032 scenario where a large Varda Pharma Factory attracts a semiconductor company seeking to establish an orbiting fab.
- Investment strategy targets an even balance between human-rated and autonomous technologies to accelerate a low Earth orbit economy, with a specific focus on pharmaceuticals due to their willingness for long-term bets and the stagnation of small molecule formulation over the past 20 years, while non-pharmaceutical microgravity products are deemed highly unlikely to succeed.
- Varda plans to announce a pharma customer within the next quarter and hopes to evolve into a contract manufacturer for entities like TSMC, though the speaker views current "Gundo" marketing cultures as mistimed, limiting talent pools, and potentially closing industry windows for the next five to seven years.
- Long-term geopolitical forecasts predict Western Europe's decline into a "second world country" status and Eastern Europe's rise and exit from the EU over multiple decades, while a personal outlook suggests earlier parenthood is necessary to have children and grandchildren before age 50 or 60, with vocal advocacy for fatherhood intended to encourage others.